Results 141 to 150 of about 1,433 (211)

Application Value and Safety Analysis of Warfarin, Rivaroxaban, and Dabigatran Ester in Elderly Patients With Atrial Fibrillation. [PDF]

Clin Cardiol
Chen C, Tian Q, Cheng C, Ji X, Feng M, Tan H, Zhou Q.   +6 more
europepmc   +1 more source

Importance of infarct topography in determination of stroke mechanism and recurrence risk: a post-hoc analysis of the dabigatran acute treatment of stroke trial. [PDF]

BMJ Open
Cimen E, Ng K, Buck BH, Field T, Coutts SB, Gioia LC, Hill MD, Miller J, Benavente OR, Sharma M, Butcher K.   +10 more
europepmc   +1 more source

Reduced-dose of bivalirudin (without the post-procedure infusion) in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention. [PDF]

BMC Cardiovasc Disord
Wang Q, Liu Y, Yang L, Zhou T, Zhang Q, Zhang Z, Sun D, Wang X.   +7 more
europepmc   +1 more source

Early versus delayed DOAC after ischaemic stroke in atrial fibrillation: 1-year outcomes in the TIMING study and in concurrent practice. [PDF]

Eur Stroke J
Fasth O, Oldgren J, Ghukasyan Lakic T, Hijazi Z, Norrving B, Wester P, Åsberg S.   +6 more
europepmc   +1 more source

Comparison of Safety and Effectiveness Between Direct Oral Anticoagulants and Vitamin K Antagonists in Dementia Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Alshehri AM, Alfehaid L, Alhawas S, Alsuwaylihi A, Alarifi A, Al Yami MS.   +5 more
europepmc   +1 more source

The impact of antithrombin III supplementation on prognosis during extracorporeal membrane oxygenation: a systematic review and meta-analysis. [PDF]

Ann Med
Zeng YT, Liu YN, Chen ZH, Chen Q, Sun KP.   +4 more
europepmc   +1 more source

A single-dose, four-cycle, fully repetitive crossover bioequivalence of dabigatran etexilate in Chinese. [PDF]

BMC Pharmacol Toxicol
Yang Z, Li Q, Yu D, Zhang X, Wang Y, Liu S, Chen L, Zhou Y, Zeng C, Zeng Y, Cai C, Xiong Y, Zhang Q, Li N, Du P, Liu L, Chen J, He Y.   +17 more
europepmc   +1 more source

BMI differences on anticoagulation with bivalirudin vs. heparin during primary PCI: a BRIGHT-4 subanalysis. [PDF]

BMC Med
Zhang D, Li Y, Qiu M, Liang Z, Xu K, Li Y, Zhang G, Xie W, Zeng H, Cheng Y, Liu J, Cheng X, Zeng Q, Zhu K, Hu J, Cheng K, Wang J, Cheng R, Zhou Y, Wang B, Cao G, Han Y, Stone GW.   +22 more
europepmc   +1 more source

The efficacy and safety of bivalirudin and heparin in patients with acute coronary syndrome: a systematic review and meta-analysis. [PDF]

Syst Rev
Zhai Y, Shang H, Li Y, Zhang N, Zhang J, Wu S.   +5 more
europepmc   +1 more source

Prior Anticoagulation and Risk of Hemorrhagic Transformation in Acute Stroke: A Post Hoc Analysis of the PRODAST Study. [PDF]

J Am Heart Assoc
Grosse GM, Hüsing A, Stang A, Kuklik N, Brinkmann M, Grond M, Rollnik JD, Marquardt L, Kraft A, Schlemm E, Eggers C, Eschenfelder CC, Weimar C, Diener HC.   +13 more
europepmc   +1 more source